Clinical Trials Browser

INDUSTRY × Myelodysplastic Syndromes × treosulfan × Clear all

NCT05534620 2026-05-20

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Phase 1 Completed

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00822393 2020-07-30

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Phase 3 Completed

570 enrolled 1 FDA

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02333058 2020-05-04

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Phase 2 Completed

Myelodysplastic Syndromes

NCT01062490 2010-02-04

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes